International Archives of Allergy and Immunology

Original Paper

Roles of CD4+ and CD8+ T Cells in Adjuvant Activity of Diesel Exhaust Particles in Mice

Fujimaki H.a · Ui N.b · Ushio H.a · Nohara K.a · Endo T.b

Author affiliations

aNational Institute for Environmental Studies, Onogawa, Tsukuba, Ibaraki, and bJikei University School of Medicine, Nishishinbashi, Minato-ku, Tokyo, Japan

Related Articles for ""

Int Arch Allergy Immunol 2001;124:485–496

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: April 27, 2001
Issue release date: April 2001

Number of Print Pages: 12
Number of Figures: 7
Number of Tables: 2

ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)

For additional information: https://www.karger.com/IAA

Abstract

Through an imbalance in Th1 and Th2 cytokine profiles, diesel exhaust particles (DEP) are thought to induce Th2-dominated IgE and IgG1 production. However, the roles of CD4+ and CD8+ T-cell subtypes in the increased immune responses to antigen in mice exposed to DEP are unclear. In the present study, we investigated whether treatment with anti-CD4 or anti-CD8 mAb abrogated the adjuvant activity of DEP. On day –1 and day 1, each group of mice was injected intraperitoneally with anti-CD4, anti-CD8, or rat IgG (vehicle). On day 0, the mice were immunized with ovalbumin (OVA) or OVA plus DEP. After 3 weeks, each mouse was boosted with 10 µg of OVA alone. On day 7 after the first injection with OVA+DEP or OVA alone, the numbers of total, IA+, CD80+/IA+ and CD86+/IA+ cells in peritoneal exudate cells (PEC) were higher in OVA+DEP-immunized mice than in OVA-immunized mice. Depletion of CD8+ cells resulted in a modulation of the production of granulocyte-macrophage colony-stimulating factor, IL-12 and PGE2 in peritoneal exudate fluid from OVA+DEP-immunized mice. On day 28, DEP injection markedly increased IL-4 production in the culture supernatants of spleen cells from CD4+ or CD8+-depleted mice. Depletion of CD8+ cells in OVA+DEP-immunized mice resulted in a decrease in IFN-γ production compared with that in OVA-immunized mice. Adjuvant activity of DEP was observed in anti-OVA IgE, anti-OVA IgG1, anti-OVA IgG3, and total IgE production. Depletion of CD4+ T cells abrogated the adjuvant effect of DEP on anti-OVA IgE, and anti-OVA IgG1 production in plasma. However, depletion of CD8+ T cell inhibited the upregulated anti-OVA IgG3 production. These findings suggest that DEP injection may affect not only the function of CD4+ cells but also that of CD8+ T-cell subsets to modulate the synthesis of proinflammatory cytokine in PEC and type-1 and type-2 cytokine production in spleens.

© 2001 S. Karger AG, Basel




Related Articles:


References

  1. Kaneko S, Shimada K, Horiuchi H, Endo A, Kodama M, Shinoda N, Imai T, Takiguchi K: Nasal allergy and air pollution. Oto-rhino-laryngology (Tokyo) 1980;23(suppl 4):270–281.
  2. Pope CA 3rd, Dockery DW, Spengler JD, Raizenne ME: Respiratory health and PM10 pollution. A daily time series analysis. Am Rev Respir Dis 1991;144:668–674.
  3. Magnussen H, Jorres R, Nowak D: Effect of air pollution on the prevalence asthma and allergy. Thorax 1993;48:879–881.
  4. Leikauf GD, Kline S, Albert RE, Baxter CS, Bernstein DI, Bernstein J, Buncher CR: Evaluation of a possible association of urban air toxics and asthma. Envrion Health Perspect 1995;103(suppl 6):253–271.
  5. Ishizaki T, Koizumi K, Ikemori R, Ishiyama Y, Koshibiki E: Studies of prevalence of Japanese cedar pollinosis among the residents in a densely cultivated area. Ann Allergy 1987;58:265–270.
  6. Schwartz J, Slater D, Larson TV, Pierson WE, Koenig JQ: Particulate air pollution and hospital emergency room visits for asthma in Seattle. Am Rev Respir Dis 1993;147:826–831.
  7. Muranaka M, Suzuki S, Koizumi K, Takafuji S, Miyamoto T, Ikemori R, Tokiwa H: Adjuvant activity of diesel-exhaust particulates for the production of IgE antibody in mice. J Allergy Clin Immunol 1986;77:616–623.
  8. Takafuji S, Suzuki S, Koizumi K, Tadokoro K, Miyamoto T, Ikemori R, Muranaka M: Diesel-exhaust particulates inoculated by the intranasal route have an adjuvant activity for IgE production in mice. J Allergy Clin Immunol 1987;79:639–645.
  9. Fujimaki H, Nohara O, Ichinose T, Watanabe N, Saito S: IL-4 production in mediastinal lymph node cells in mice intratracheally instilled with diesel exhaust particulates and antigen. Toxicology 1994;92:261–268.
  10. Fujimaki H, Saneyoshi K, Nohara O, Shiraishi F, Imai T: Intranasal instillation of diesel exhaust particulates and antigen in mice modulated cytokine productions in cervical lymph node cells. Int Arch Allergy Immunol 1995;108:268–273.
    External Resources
  11. Kobayashi T, Ito T: Diesel exhaust particulates induce nasal mucosal hyperresponsiveness to inhaled histamine aerosol. Fundam Appl Toxicol 1995;27:195–202.
  12. Takano H, Yoshikawa T, Ichinose T, Miyabara Y, Imaoka K, Sagai M: Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med 1997;156:36–42.
  13. Diaz-Sanchez D, Tsien A, Casillas A, Dotson AR, Saxon A: Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J Allergy Clin Immunol 1996;98:114–123.
  14. Diaz-Sanchez D, Tsien A, Fleming J, Saxon A: Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol 1997;158:2406–2413.
  15. Bayram H, Devalia JL, Sapsford RJ, Ohtoshi T, Miyabara Y, Sagai M, Davies RJ: The effect of diesel exhaust particles on cell function and release of inflammatory mediators from human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1998;18:441–448.
  16. Ohtoshi T, Takizawa H, Okazaki H, Kawasaki S, Takeuchi N, Ohta K, Ito K: Diesel exhaust particles stimulate human airway epithelial cells to produce cytokines relevant to airway inflammation in vitro. J Allergy Clin Immunol 1998;101:778–785.
  17. Terada N, Maesako K, Hiruma K, Hamano N, Houki G, Konno A, Ikeda T, Sai M: Diesel exhaust particulates enhance eosinophil adhesion to nasal epithelial cells and cause degranulation. Int Arch Allergy Immunol 1997;114:167–174.
    External Resources
  18. Saneyoshi K, Nohara O, Imai T, Shiraishi F, Moriyama H, Fujimaki H: IL-4 and IL-6 production of bone marrow-derived mast cells is enhanced by treatment with environmental pollutants. Int Arch Allergy Immunol 1997;114:237–245.
  19. Mosmann TR, Chewinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clones. 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;135:2348–2357.
  20. Croft M, Carter L, Swain SL, Dutton RW: Generation of polarized antigen-specific CD8+ effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 1994;180:1715–1728.
  21. Sad S, Marcotte R, Mosmann TR: Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995;2:271–279.
  22. Noble A, Macary PA, Kemeny DM: IFN-gamma and IL-4 regulate the growth and differentiation of CD8+ T cells into subpopulations with distinct cytokine profiles. J Immunol 1995;155:2928–2937.
  23. Sagai M, Saito H, Ichinose T, Kodama M, Mori Y: Biological effects of diesel exhaust particles. 1. In vitro production of superoxide and in vivo toxicity in mouse. Free Radic Biol Med 1993;14:37–47.
  24. Yang M, Cao Y, Mohapatra SS: CD8+ T cells inhibit immunoglobulin E synthesis in low responder SJL/J mice. Immunology 1998;93:230–237.
  25. Gold KN, Weyand CM, Goronzy JJ: Modulation of helper T cell function by prostaglandins. Arthritis Rheum 1994;37:925–933.
  26. Katamura K, Shintaku N, Yamauchi Y, Fukui T, Ohshima Y, Mayumi M, Furusho K: Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5. J Immunol 1995;155:4604–4612.
  27. De Becker G, Moulin V, Tielemans F, De Mattia F, Urbain J, Leo O, Moser M: Regulation of T helper cell differentiation in vivo by soluble and membrane proteins provided by antigen-presenting cells. Eur J Immunol 1998;28:3161–3171.
  28. Sonoda KH, Matsuzaki G, Nomura A, Yamada H, Hamano S, Nakamura T, Mukasa A, Nomoto K: Macrophages activated by Listeria monocytogenes induce organ-specific autoimmunity. Immunology 1997;92:274–283.
    External Resources
  29. Schweitzer AN, Sharpe AH: Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J Immunol 1998;161:2762–2771.
    External Resources
  30. Nel AE, Diaz-Sanchez D, Ng D, Hiura T, Saxon A: Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. J Allergy Clin Immunol 1998;102:539–554.
  31. Zsebo KM, Yuschenkoff VN, Schiffer S, Chang D, McCall E, Dinarello CA, Brown MA, Altrock B, Bagby GC Jr: Vascular endothelial cells and granulopoiesis: Interleukin-1 stimulates release of G-CSF and GM-CSF. Blood 1988;71:99–103.
    External Resources
  32. Dinarello CA: Interleukin-1; in Thomson A (ed): The Cytokine Handbook. London, Academic Press, 1994, pp 31–56.
  33. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harlan JM, Klebanoff SJ, Waltersdorph A, Wong G, Clark SC, Vadas MA: Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986;78:1220–1228.
  34. Sakamoto KM, Golde DW, Gasson JC: The biology and clinical applications of granulocyte-macrophage colony-stimulating factor. J Pediatr 1991;118:S17–S20.
    External Resources
  35. Yang H-M, Ma JYC, Castranova V, Ma JKH: Effects of diesel exhaust particles on the release of interleukin-1 and tumor necrosis factor-alpha from rat alveolar macrophages. Exp Lung Res 1997;23:269–284.
  36. Holmes BJ, Diaz-Sanchez D, Lawrence RA, Bell EB, Maizals RM, Kemeny DM: The contrasting effects of CD8+ T cells on primary, established and Nippostrongylus brasiliensis-induced IgE responses. Immunology 1996;88:252–260.
    External Resources
  37. Holmes BJ, MacAry PA, Noble A, Kemeny DM: Antigen-specific CD8+ T cells inhibit IgE responses and interleukin-4 production by CD4+ T cells. Eur J Immunol 1996;27:2657–2665.
  38. Barnes PJ, Lim S: Inhibitory cytokines in asthma. Mol Med Today 1998;4:452–458.
  39. Zeh H JIII, Tahara H, Lotze MT: Interleukin-12; in Thomson A (ed): The Cytokine Handbook. London, Academic Press, 1994, pp 239–256.
  40. Demeure CE, Yang LP, Desjardins C, Raynauld P, Delespesse G: Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines. Eur J Immunol 1997;27:3526–3531.
    External Resources
  41. Huang TJ, Macary PA, Kemeny DM, Chung KF: Effect of CD8+ T-cell depletion on bronchial hyper-responsiveness and inflammation in sensitized and allergen-exposed Brown-Norway rats. Immunology 1999;96:416–423.
  42. Mosmann TR, Coffman RL: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145–173.
  43. Snapper CM, Mond JJ: Towards a comprehensive view of immunoglobulin class switching. Immunol Today 1993;14:15–17.
  44. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S: Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MLR mice. J Clin Invest 1996;97:1597–1604.
    External Resources
  45. Gavin AL, Barnes N, Dijstelbloem HM, Hogarth PM: Identification of the mouse IgG3 receptor: Implications for antibody effector function at the interface between innate and adaptive immunity. J Immunol 1998;160:20–23.
    External Resources
  46. Baz A, Richieri A, Puglia A, Nieto A, Dematteis S: Antibody response in CD4-depleted mice after immunization or during early infection with Echinococcus granulosus. Parasite Immunol 1999;21:141–150.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: April 27, 2001
Issue release date: April 2001

Number of Print Pages: 12
Number of Figures: 7
Number of Tables: 2

ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)

For additional information: https://www.karger.com/IAA


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP